Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Williams

Showing results (31-40 of 102) with videos related to

Pageof 11
Sort By:
Journal of Clinical Lipidology|December 16, 2014
The Risk-Benefit Paradigm vs the Causal Exposure Paradigm: LDL as a primary cause of vascular diseasePeter P Toth, George Thanassoulis, Ken Williams, et al.
BMJ (Clinical Research Ed.)|August 24, 2004
Access to high cost drugs in AustraliaChristine Y Lu, Ken Williams, Ric Day, et al.
The American Journal of Cardiology|May 15, 2012
Comparison of coronary calcium screening versus broad statin therapy for patients at intermediate cardiovascular riskAllan D Sniderman, George Thanassoulis, Patrick R Lawler, et al.
Circulation|April 6, 2006
Progression of plasminogen activator inhibitor-1 and fibrinogen levels in relation to incident type 2 diabetesAndreas Festa, Ken Williams, Russell P Tracy, et al.
Genetic Epidemiology|September 6, 2002
Genetic determination of biological age in the Mennonites of the Midwestern United StatesRavindranath Duggirala, Meredith Uttley, Ken Williams, et al.
Journal of Clinical Lipidology|July 28, 2012
Is lower and lower better and better? A re-evaluation of the evidence from the Cholesterol Treatment Trialists' Collaboration meta-analysis for low-density lipoprotein loweringAllan Sniderman, George Thanassoulis, Patrick Couture, et al.
Circulation|August 25, 2004
National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart StudyKelly J Hunt, Roy G Resendez, Ken Williams, et al.
Diabetes|December 25, 2003
Mode of onset of type 2 diabetes from normal or impaired glucose toleranceEle Ferrannini, Monica Nannipieri, Ken Williams, et al.
Journal of Clinical Lipidology|June 4, 2013
Counterpoint: statins do reduce fatal eventsAllan D Sniderman, George Thanassoulis, Patrick Couture, et al.
Annals of Epidemiology|July 31, 2007
The metabolic syndrome and the impact of diabetes on coronary heart disease mortality in women and men: the San Antonio Heart StudyKelly J Hunt, Ken Williams, Helen P Hazuda, et al.
Pageof 11

Showing results (31-40 of 102) with videos related to

Sort By:
Pageof 11
Journal of Clinical Lipidology|December 16, 2014
The Risk-Benefit Paradigm vs the Causal Exposure Paradigm: LDL as a primary cause of vascular diseasePeter P Toth, George Thanassoulis, Ken Williams, et al.
BMJ (Clinical Research Ed.)|August 24, 2004
Access to high cost drugs in AustraliaChristine Y Lu, Ken Williams, Ric Day, et al.
The American Journal of Cardiology|May 15, 2012
Comparison of coronary calcium screening versus broad statin therapy for patients at intermediate cardiovascular riskAllan D Sniderman, George Thanassoulis, Patrick R Lawler, et al.
Circulation|April 6, 2006
Progression of plasminogen activator inhibitor-1 and fibrinogen levels in relation to incident type 2 diabetesAndreas Festa, Ken Williams, Russell P Tracy, et al.
Genetic Epidemiology|September 6, 2002
Genetic determination of biological age in the Mennonites of the Midwestern United StatesRavindranath Duggirala, Meredith Uttley, Ken Williams, et al.
Journal of Clinical Lipidology|July 28, 2012
Is lower and lower better and better? A re-evaluation of the evidence from the Cholesterol Treatment Trialists' Collaboration meta-analysis for low-density lipoprotein loweringAllan Sniderman, George Thanassoulis, Patrick Couture, et al.
Circulation|August 25, 2004
National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart StudyKelly J Hunt, Roy G Resendez, Ken Williams, et al.
Diabetes|December 25, 2003
Mode of onset of type 2 diabetes from normal or impaired glucose toleranceEle Ferrannini, Monica Nannipieri, Ken Williams, et al.
Journal of Clinical Lipidology|June 4, 2013
Counterpoint: statins do reduce fatal eventsAllan D Sniderman, George Thanassoulis, Patrick Couture, et al.
Annals of Epidemiology|July 31, 2007
The metabolic syndrome and the impact of diabetes on coronary heart disease mortality in women and men: the San Antonio Heart StudyKelly J Hunt, Ken Williams, Helen P Hazuda, et al.
Pageof 11